A new therapeutic paradigm has heightened the need for meaningful measures of assessing patients. As new treatments have become available for people with 5q spinal muscular atrophy (SMA), a new report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback